Abstract
In the twenty or so years since platelets first became available in a highly concentrated form for transfusion to thrombocytopenic patients, platelet therapy has established itself as an integral and vital component in the management of such patients. Dramatic changes in medical practice, and the full-fledged development of medical oncology as a separate discipline, owe much to the expanding blood component technology which has provided them with highly concentrated preparations of viable and hemostatically competent platelets. Surgery, trauma, chemotherapy and radiotherapy have, as well, all been altered by the ready availability of platelet concentrates. Whereas in the 1960s, over 75% of deaths in acute leukemia were the result of hemorrhage directly attributable to thrombocytopenia (37), this figure has been radically lowered to no more than 10% to 20%, at this time. Chemotherapy and radiotherapy continue to push to the limits of bone marrow tolerance, and surgery is undertaken in thrombocytopenic patients formerly considered inoperable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aisner, J.: Clinical use of platelet transfusions for patients with cancer. In: Platelet Physiology and Transfusion. Washington, D.C., American Association of Blood Banks, 1978, p.39.
Aisner, J., Schiffer, C.A., Wolff, J.H. et al.: A standardized technique for efficient platelet and leukocyte collection using the Model 30 Blood Processor. Transfusion 16:437, 1976.
Ashurst, D.E., Bedford, D., Coombs, R.R.A.: Examination of human platelets for the ABO, MN, Rh, Tja, Lutheran and Lewis system of antigens by means of mixed erythrocyte-platelet agglutination. Vox. Sang. 1:235, 1956.
Aster, R.H.: Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood 26:732, 1965
Aster, R.H.: J. Clin. Invest. 45:645, 1966.
Aster, R.H.: The Platelet. Baltimore, Williams and Wilkins, 1971, p. 153.
Aster, R.H.: Hematology. New York, McGraw-Hill, 1977, p. 1341.
Aster, R.H.: Hematology, ed. 2. New York, McGraw-Hill Book Co. Inc., 1977, p. 1317.
Aster, R.H., Jand1, J.H.: Platelet sequestration in man. I. Methods. J. Clin. Invest. 43:843, 1964.
Aster, R.H., Szatkowski, N., Liebert, M. et al.: Expression of HLAB12, HLA-B8, w4, and w6 on platelets. Transplant. Proc. 9:1965, 1977.
Bachman, F., McKenna, R., Cole, E.R. et al.: The hemostatic mechanism after open-heart surgery. J. Thorac. Cardiovasc. Surg. 70:76, 1975
Barbui, T., Baudo, F., Ciavarella, N. et al.: Spectrum of Von Willebrand’s disease: a study of 100 cases. Br. J. Haematol. 35:101, 1977
Bick, R.L., Schmalhorst, W.R., Arbegast, N.R.: Alterations of hemostasis associated with cardiopulmonary bypass. Thromb. Res. 8:285, 1976.
Bowie, E.J., Owen, C.A. Jr.: Hemostatic failure in clinical medicine. Semin. Hematol. 14:341, 1977.
Brand, A., Van Leeuwen, A., Eernisse, J.G. et al.: Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 51:781, 1978.
Brand, A., Van Leeuwen, A., Eernisse, J.G. et al.: Platelet immunology with special regard to platelet transfusion therapy. Excerpta Medica Int. Congress Series No. 415:639, 1978.
Button, L.N., De Wolf, W., Newburger, P. et al.: The effect of irradiation upon blood components. In: Proceedings of the 17th International Congress of Hematology, in press.
Chediak, J., Maxey, B., Desser, R.: Successful management of bleeding in a patient with a Factor V inhibitor by platelet transfusions, abstracted. Blood 54:273a, 1979.
Cohen, E., Feliciano, H., Glidewell, O.: Platelet increments following transfusion of ABO group specific and nonspecific platelets. Transfusion, 8:310, 1968.
Cohen, P., Gardner, F.H.: Platelet preservation. H. Preservation of canine platelet concentrates by freezing in solutions of glycerol plasma. J. Clin. Invest. 41:10, 1962.
Colombani, J.: Blood platelets in HL-A serology. Transplant. Proc. 3:1078, 1971.
Coombs, R.R.A., Bedford, D.: The A and B antigens on human platelets demonstrated by means of mixed erythrocyte platelet agglùtination. Vox. Sang. 5:11, 1955.
Counts, R.B., Haisch, C., Simon, T.L. et al.: Hemostasis in massively transfused trauma patients. Ann. Surg. 190:91, 1979.
Daly, P.A., Schiffer, C.A., Aisner, J. et al.: Successful transfusion of platelets cryopreserved for more than 3 years. Blood, 54:1023, 1979.
Daly, P.A., Schiffer, C.A., Aisner, J. et al.: Platelet transfusion therapy: One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA 243:435, 1980.
Dayian, G., Pert, J.H.: A simplified method for freezing human blood platelets in glycerol-glucose using a statistically controlled cooling rate device. Transfusion 19:255, 1979.
Dayian, G., Rowe, A.W.: Cryopreservation of human platelets for transfusion: A glycerol-glucose, moderate rate cooling procedure. Cryobiology 13:1, 1976.
Duquesnoy, R.J., Anderson, A.J., Tomasulo, P.A. et al.: ABO compatibility and platelet transfusion of alloimmunized thrombocytopenic patients. Blood 54:595, 1979.
Duquesnoy, R.J., Filin, D.J., Aster, R.H.: Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients. Blood 50:407, 1977.
Duquesnoy, R.J., Filip, D.J., Rodey, G.E. et al.: Successful transfusion of platelets ‘mismatched’ for HLA antigens to alloimmunized thrombocytopenic patients. Am. J. Hematol. 2:219, 1977.
Duquesnoy, R.J., Filip, D.J., Tomasulo, P.A. et al.: Role of HLA-C matching in histocompatible platelet transfusion therapy of allo-immunized thrombocytopenic patients. Transplant. Proc. 9:1827, 1977.
Duquesnoy, R.J., Testin, J., Aster, R.H.: Variable expression of w4 and w6 on platelets. Possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients. Transplant. Proc. 9:1829, 1977.
Eisner, E.V., Shahidi, N.T.: Immune thrombocytopenia due to a drug metabolite. N. Engl. J. Med. 187:376, 1972.
Federal Register, Proposed Rules. Washington, D.C., Jan. 15, 1980 Vol. 45, No. 10, p. 2852.
Food and Drug Administration: Code of Federal Regulations, Platelet concentrates (human), Sect. 640.24, Processing, p. 119.
Freireich, E.J., Kliman, A., Gaydos, L.A. et al.: Response to repeated platelet transfusion from the same donor. Ann. Intern. Med. 59:277, 1963.
Gaydos, L.A., Freireich, E.J., Mantel, N.: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N. Engl. J. Med. 266:905, 1962.
Gloster, E.S., Strauss, R.A.: Clinical Hematology for Blood Bankers. Inherited and acquired platelet disorders, p. 183–213, 1979.
Gmur, J., Von Felten, A., Frick, P.: Platelet support in polysensitized patients: Role of HLA specificities and crossmatch testing for donor selection. Blood 51:903, 1978.
Goldfinger, D., McGinniss, M.H.: Rh-incompatible platelet transfusions - risks and consequences of sensitizing immunosuppressed patients. N. Engl. J.Med. 284:942, 1971.
Graw, R.G. Jr., Herzig, G.P., Eisel, R.J. et al.: Leukocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 11:94, 1971.
Greenwalt, T.J., Jamieson, G.A. (eds.): The Blood Platelet in Transfusion Therapy. New York, Alan R. Liss Inc., 1978.
Grumet, F.C., Yankee, R.A.: Long-term platelet support of patients with aplastic anemia. Ann. Intern. Med. 73:1, 1970.
Gunson, H.H., Stratton, F., Cooper, D.G. et al.: Primary immunization of Rh-negative volunteers. Br. Med. J. 1:593, 1970.
Gurevitch, J., Nelken, D.: ABO groups in blood platelets. J. Lab. Clin. Med. 44:562, 1954.
Gurevitch, J., Nelken, D.: Studies on platelet antigens III. Rh-Hr antigens in platelets. Vox. Sang. 2:342, 1957.
Handin, R.I., Valeri, C.R.: Improved viability of previously frozen platelets. Blood 40:509, 1972.
Harbury, C.B., Galvan, C.: Surgically acquired platelet storage pool deficiency, abstracted. Proceedings of the 18th Annual Meeting of the American Society of Hematology, 1975, p. 195.
Harker, L.A.: The role of the spleen in thrombokinetics. J. Lab. Clin. Med. 77:247, 1971..
Harker, L.A., Slichter, S.J.: The bleeding time as a screening test for evaluation of platelet function. N. Engl. J. Med. 287: 155, 1972.
Hathaway, W.E.: Bleeding disorders due to platelet dysfunction. Am. J. Dis. Child. 121:127, 1971.
Hester, J.P., McCredie, K.B., Freireich, E.J.: Platelet replacement therapy: A clinical assessment. The Blood Platelet in Transfusion Therapy. New York, Alan R. Liss Inc. 1978, p. 281.
Herzig, R.H., Herzig, G.P., Bull, M.I. et al.: Correction of poor platelet transfusion responses with leukocyte-poor HLA-matched platelet concentrates. Blood 46:743, 1975.
Higby, D.J., Cohen, E., Holland, J.F. et al.: The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study. Transfusion 14:440, 1974.
Holley, T.R., Van Epps, D.E., Harvey, R.I. et al.: Effect of high doses of radiation on human neutrophil chemotaxis, phagocytosis, and morphology. Am. J. Pathol. 75:61, 1974.
Howard, J.E., Perkins, H.A.: The natural history of alloimmunization to platelets. Transfusion, 18:496, 1978.
Koepke, J.A., Wu, K.K., Hoak, J.C. et al.: A comparison of platelet production methods suitable for a service-oriented blood dollar center. Transfusion 15:39, 1957.
Krevans, S.R., Jackson, D.P.: Hemorrhagic disorder following massive whole blood transfusions. JAMA 159:171, 1955.
Lackner, H.: Hemostatic abnormalities associated with dysproteinemias. Semin. Hematol. 10:125, 1973.
Lawler, S.D., Shatwell, H.S.: Are Rh antigens restricted to red cells? Vox. Sang. 7:488, 1962.
Lewis, J.H., Draude, J., Kuhns, W.J.: Coating of ‘O’ platelets with A and B group substances. Vox. Sang. 5:434, 1960.
Liebert, M., Aster, R.H.: Expression of HLA-B12 on platelets, on lymphocytes and in serum: A quantitative study. Tissue Antigens 9:199, 1977.
Lim, R.C. Jr., Olcott, C.IV, Robinson, A.J.: Platelet response and coagulation changes following massive blood replacement. J. Trauma 13:577, 1973.
Lohrmann, H., Bull, M.I., Decter, J.A. et al.: Platelet transfusion from HL-A compatible unrelated donors to alloimmunized patients. Ann. Intern. Med. 80:9, 1974.
McKenna, R., Bachmann, F., Whittaker, B. et al.: The hemostatic mechanism after open heart surgery. J. Thorac. Cardiovasc. Surg. 70:298, 1975.
McKenzie, F.N., Dhall, D.P., Arfors, K.E., et al: Blood platelet behaviour during and after open heart surgery. Br. Med. J. 2:795, 1969.
Mielke, C.H. Jr., Kaneshiro, M.M., Maher, I.A. et al.: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204, 1969.
Miller, R.O., Robbins, T.O., Tong, M.J. et al.: Coagulation defects associated with massive blood transfusion. Am. Surg. 174:794, 1971.
Mittal, K.K., Rider, E.A., Green, D.: Matching of histocompatibility (HLA-A) antigens for platelet transfusion. Blood 47:31, 1976.
Mittal, K.K., Terasaki, P.I.: Serological crossreactivity in the HLA system. Tissue Antigens 2:146, 1974.
Moriau, M., Masure, R., Hurlet, A. et al.: Hemostasis disorders in open heart surgery with extracorporeal circulation. Vox. Sang. 32:41, 1977.
Morrison, F.S.: The effect of filters on the efficiency of platelet transfusion. Transfusion 6:493, 1966.
Murphy, S., Koch, P.A., Evans, A.E.: Randomized trial of prophylactic vs. therapeutic platelet transfusion in childhood acute leukemia, abstracted. Clin. Res. 24:379a, 1976.
Murphy, S., Sayar, S.N., Abdou, N.L. et al.: Platelet preservation by freezing. Use of dimethylsulfoxide as cryoprotective agent. Transfusion 14:139, 1974.
Nagasawa, T., Kim, B.K., Baldini, M.G.: Temporary suppression of circulating antiplatelet alloantibodies by the massive infusion of fresh, stored, or lyophilized platelets. Transfusion 18:429, 1978.
Nakamoto, S., Kolff, W.J.: Hemorrhagic diathesis in uremia and the avoidance of bleeding problems during dialysis. Ann. N.Y. Acad. Sci. 115:348, 1964.
Nusbacher, J., Scher, M.L., MacPherson, J.L.: Plateletpheresis using the Haemometics Model 30 Cell Separator. Vox. Sang. 33:9, 1977
Opeiz, G., Terasaki, P.I.: Improvement of kidney-graft survival with increased numbers of blood transfusions. N. Engl. J. Med. 299:799, 1978.
Pfisterer, H., Thierfelder, S., Stich, W. et al.: ABO Rh blood groups and platelet transfusion. Blut 17:1, 1968.
Rabiner, S.F.: Uremic bleeding. Prog. Hemostas. Thromb. 1:233, 1972
Roy, A.J., Jaffe, N., Djerassi, I.: Prophylactic platelet transfusions in children with acute leukemia: A dose response study. Transfusion 13:283, 1973.
Schiffer, C.A. (ed.): Platelet Physiology and Transfusion. Washington DC, American Association of Blood Banks, 1978.
Schiffer, C.A., Aisner, J., Wiernik, P.H.: Platelet transfusion therapy for patients with leukemia. The Blood Platelet in Transfusion Therapy. New York, Alan R. Liss Inc., pp. 276–279, 1978.
Schiffer, C.A., Aisner, J., Wiernik, P.H.: Frozen autologous platelet transfusion for patients with leukemia. N. Engl. J. Med. 299:7, 1978.
Schiffer, C.A., Buchholz, D.H., Wiernik, P.H.: Intensive multiunit plateletpheresis of normal donors. Transfusion 16:321, 1976.
Schiffer, C.A., Lichtenfeld, J.L., Wiernik, P.H. et al.: Antibody response in patients with acute leukemia. Cancer 37:2177, 1976.
Schiffer, C.A., Weinstein, J.H., Wiernik, P.H.: Methicillin associated thrombocytopenia. Ann. Intern. Med. 85:338, 1976.
Schiffer, L.M., Atkins, H.L., Chanana, A.D. et al.: Extracorporeal irradiation of the blood in humans. Effects upon erythrocyte survival. Blood 27:831, 1966.
Sheldon, G.F., Lim, R.C.Jr., Blaisdell, F.W.: The use of fresh blood in treatment of critically injured patients. J. Trauma 15: 670, 1975.
Shulman, N.R.: Immunological considerations attending platelet transfusion. Transfusion 6:39, 1966.
Shulman, N.R., Marder, V.J., Hiller, M.C. et al.: Platelet and leukocyte isoantigens and their antibodies: serologic, physiologic and clinical studies. Prop. Hematol. 4:222, 1964.
Shulman, N.R., Watkins, S.P. Jr., Itscoitz, S.B. et al.: Evidence that the spleen retains the youngest and hemostatically most effective platelets. Trans. Assoc. Am. Physicians 81:302, 1968.
Silvergleid, A.J., Hafgleid, E.B., Harabin, M.A.: Clinical value of washed-platelet concentrates in patients with non-hemolytic transfusion reactions. Transfusion 17:33, 1976.
Simon, T.L., Henderson, R.: Coagulation factor activity in platelet concentrates. Transfusion 19:186, 1979.
Simpson, J.G., Stalher, A.L.: The concept of disseminated intra-vascular coagulation. Clin. Haematol. 2:189, 1973.
Simpson, M.B.: Platelet function and transfusion therapy in the surgical patient. Platelet Physiology and Transfusion. Washington, DC, American Association of Blood Banks, p. 51–67, 1978.
Slichter, S.J.: Selection of compatible platelet donors. Platelet Physiology and Transfusion. Washington, DC, American Association of Blood Banks, pp. 83–92, 1978.
Solomon, J., Bentler, E., Bofenkamp, R. et al.: Indication for the administration of platelet transfusions during remission induction therapy of acute leukemia, abstracted. Blood 50(suppl.):210, 1977.
Spector, J.I., Yarmala, J.A., Marchionni, L.D. et al.: Viability and function of platelets frozen at 2 to 3C per minute with 4 or 5 per cent DMSO and stored at -80°C for 8 months. Transfusion 17: 8, 1977.
Stefanini, M.: Studies on the hemostatic breakdown during massive replacement transfusions. Am. J. Med. Sci. 244:298, 1962.
Stern, K., Davidson, I., Masartis, L.: Experimental studies on Rh immunization. Am. J. Clin. Pathol. 26:833, 1956.
Stuart, M.J., Murphy, S., Oski, F.A. et al.: Platelet function in recipients of platelets from donors ingesting aspirin. N. Engl. J. Med. 287:1105, 1972.
Svejgaard, A., Kissmeyer-Nielsen, F.: Crossreactive human HLA isoantibodies. Nature 219:868, 1968.
Svejgaard, A., Kissmeyer-Nielsen, F., Thorsby, E.: HL-A typing of platelets. Histocompatibility Testing 1970. Copenhagen, Munksgaard, p. 160, 1970.
Szymanski, I.O., Patti, K., Kliman, A.: Efficacy of the Latham Blood Separator to perform plateletpheresis. Transfusion 13:405, 1973.
Technical Manual, ed. 7. Washington, DC, American Association of Blood Banks, p. 240, 1977.
Thorsby, E., Hegelson, A., Gjendal, T.: Repeated platelet transfusions from HLA compatible unrelated sibling donors. Tissue Antigens 2:397, 1972.
Tomasulo, P.A.: Management of the alloimmunized patient with HLAmatched platelets. Platelet Physiology and Transfusion. Washington, DC, American Association of Blood Banks, p. 69–81, 1978.
Tosato, G., Applebaum, R., Deisseroth, A.B.: HLA-matched platelet transfusion therapy of severe aplastic anemia. Blood 52:846, 1978.
Tosato, G., Appelbaum, F.R., Trapani, R.J. et al.: Use of in vitro assays in selection of compatible platelet donors. Transfusion 20: 47, 1980.
Valeri, C.R.: Hemostatic effectiveness of liquid-preserved and previously frozen human platelets. N. Engl. J. Med. 290:353, 1974.
Valeri, C.R.: Circulation and hemostatic effectiveness of platelets stored at 4C or 22C: Studies in aspirin-treated normal volunteers. Transfusion 16:20, 1976.
Van der Weerdt, C.M.: Platelet Antigens and Isoimmunization. Thesis, Drukkerij Aemstelstad, Amsterdam, 1965.
Van Eys, J., Thomas, D., Olivos, B.: Platelet use in pediatric oncology: A review of 393 transfusions. Transfusion 18:169, 1978.
Van Rood, J.J., Van Leeuwen, A., Keuning, J. et al.: The serologic recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens 5:73, 1975.
Wiener, A.S., Sonn Gordon, A.B.: Simple method of preparing anti-Rh serum in normal male donors. Am. J. Clin. Pathol. 17:67, 1947.
Weiss, H.J., Aledort, L.M.: Impaired platelet/connective tissue reaction in man after aspirin ingestion. Lancet 2:495, 1967.
Weiss, H.J., Rogers, J.: Correction of the platelet abnormality in Von Willebrand’s disease by cryoprecipitate. Am. J. Med. 53: 734, 1972.
Weiss, H.J., Aledort, L.M., Kochwa, S.: The effect of salicylates on the hemostatic properties of platelets in man. J. Clin. Invest. 74:2169, 1968.
Wu, K.K., Hoak, J.C., Koepke, J.A. et al.: Selection of compatible platelet donors: A prospective evaluation of three cross-matching techniques. Transfusion 17:638, 1977.
Wu, K.K., Hoak, J.C., Thompson, J.S. et al.: Use of platelet aggregometry in selection of compatible platelet donors. N. Engl. J. Med. 292:134, 1975.
Yankee, R.A., Graff, K.S., Dowling, R. et al.: Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N. Engl. J. Med. 760, 1973.
Yankee, R.A., Grumet, F.C., Rogentine, G.N.: Platelet transfusion therapy: the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N. Engl. J. Med. 281:1208, 1969
Zaroulis, C.G., Spector, J.I., Emerson, C.P. et al.: Therapeutic transfusions of previously frozen washed human platelets. Transfusion 19:371, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Silvergleid, A.J. (1982). Platelet Therapy. In: Smit Sibinga, C.T., Das, P.C., van Loghem, J.J. (eds) Bloodtransfusion and Problems of Bleeding. Developments in Hematology and Immunology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7692-4_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-7692-4_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7694-8
Online ISBN: 978-94-009-7692-4
eBook Packages: Springer Book Archive